Related Experiment Video
Updated: Sep 8, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Inhibition of wild-type HIV-1 virus production by a matrix deficient Gag mutant
1Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, USA.
Abstract:
Previous studies have shown that certain HIV-1 Gag mutants can interfere with the production of infectious HIV-1 when coexpressed with wild-type virus. In this paper, we studied two mutants of HIV-1 for their ability to interfere with the production of wild-type virus. Both mutants lack the entire matrix domain of gag and either lack [myr(-)MA(-)] or contain [myr(+)MA(-)] an amino-terminal myristate (myr) addition sequence at the beginning of the capsid domain. Previously we have demonstrated that expression of both mutant constructs leads to assembly and release of mutant viruses, although only myr(+)MA(-) particles are released efficiently. Particles produced by both matrix-deficient mutants are noninfectious and poorly incorporate and/or retain viral envelope glycoproteins. In this study, we further show that expression of myr(+)MA(-), but not myr(-)MA(-) interferes with wild-type HIV-1 virus production in transient expression assays. Our data suggest that wild-type and myristylated MA(-) Gag protein interacts at some point during assembly and that Gag myristylation has a greater effect on the assembly pathway than the matrix domain.
Insights
Certain human immunodeficiency virus type 1 (HIV-1) Gag mutants interfere with wild-type virus production. Myristoylated matrix-deficient Gag mutants disrupt HIV-1 assembly, highlighting myristylation
Area of Science:
- Virology
- Molecular Biology
- HIV Research
Background:
- HIV-1 Gag protein is essential for viral assembly and release.
- Specific Gag mutants can inhibit wild-type HIV-1 production.
- Understanding Gag interactions is crucial for developing antiviral strategies.
Purpose of the Study:
- To investigate the interference of two matrix-domain-deficient HIV-1 Gag mutants with wild-type virus production.
- To determine the role of myristoylation in this interference mechanism.
Main Methods:
- Transient expression assays were used to coexpress wild-type HIV-1 with Gag mutants.
- Analysis of viral particle release, infectivity, and glycoprotein incorporation.
- Comparison of myristoylated [myr(+)MA(-)] and non-myristoylated [myr(-)MA(-)] mutants.
Main Results:
- The myristoylated matrix-deficient mutant [myr(+)MA(-)] significantly interfered with wild-type HIV-1 production.
- The non-myristoylated mutant [myr(-)MA(-)] did not show significant interference.
- Matrix-deficient mutants produced non-infectious particles with poor glycoprotein incorporation.
Conclusions:
- Gag myristoylation plays a critical role in the interference with wild-type HIV-1 production.
- Interactions between myristoylated Gag proteins occur during the viral assembly process.
- Myristoylation has a more significant impact on the HIV-1 assembly pathway than the matrix domain.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

